FOXM1 plays a role in autophagy by transcriptionally regulating Beclin-1 and LC3 genes in human triple-negative breast cancer cells

A SRSF1 self-binding mechanism restrains Mir505-3p from inhibiting proliferation of neural tumor cell lines

(2018) Kan Yang et al.   ANTI-CANCER DRUGS

The exploration of contrasting pathways in Triple Negative Breast Cancer (TNBC)

(2018) Shavira Narrandes et al.   BMC CANCER

Mechanisms of autophagy and relevant small-molecule compounds for targeted cancer therapy

(2018) Jin Zhang et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Mechanism and medical implications of mammalian autophagy

(2018) Ivan Dikic et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

mTOR Pathways in Cancer and Autophagy

(2018) Mathieu Paquette et al.   Cancers

Rapamycin rescues mitochondrial myopathy via coordinated activation of autophagy and lysosomal biogenesis

(2018) Gabriele Civiletto et al.   EMBO Molecular Medicine

The exponential growth of autophagy-related research: from the humble yeast to the Nobel Prize

(2017) Noboru Mizushima   FEBS LETTERS

Targeting LC3 and Beclin-1 autophagy genes suppresses proliferation, survival, migration and invasion by inhibition of Cyclin-D1 and uPAR/Integrin β1/ Src signaling in triple negative breast cancer cells

(2017) Zuhal Hamurcu et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Roles of FoxM1 in cell regulation and breast cancer targeting therapy

(2017) Xin Song et al.   MEDICAL ONCOLOGY

Eukaryotic Elongation Factor 2 Kinase (eEF2K) in Cancer

(2017) Xuemin Wang et al.   Cancers

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

(2016) Daniel J Klionsky et al.   Autophagy

Role of the mammalian ATG8/LC3 family in autophagy: differential and compensatory roles in the spatiotemporal regulation of autophagy

(2016) You-Kyung Lee et al.   BMB Reports

Retraction Note to: FoxM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factors

(2016) Aamir Ahmad et al.   BREAST CANCER RESEARCH AND TREATMENT

Expression of FOXM1 and related proteins in breast cancer molecular subtypes

(2016) Jeong-Ju Lee et al.   INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY

FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells

(2016) Zuhal Hamurcu et al.   Oncotarget

Prognostic Impact of Autophagy Biomarkers for Cutaneous Melanoma

(2016) Diana Y. L. Tang et al.   Frontiers in Oncology

Targeting FOXM1 auto-regulation in cancer

(2015) Andrei L Gartel   CANCER BIOLOGY & THERAPY

Targeting autophagy in cancer management – strategies and developments

(2015) Bulent Ozpolat et al.   Cancer Management and Research

Investigation of FOXM1 as a Potential New Target for Melanoma

(2015) Azusa Miyashita et al.   PLoS One

Inhibition of autophagy as a new means of improving chemotherapy efficiency in high-LC3B triple-negative breast cancers

(2014) Sylvain Lefort et al.   Autophagy

Eukaryotic elongation factor 2 kinase confers tolerance to stress conditions in cancer cells

(2014) Hongcheng Zhu et al.   CELL STRESS & CHAPERONES

Triple-Negative Breast Cancer and the Need for New Therapeutic Targets

(2013) Olav Engebraaten et al.   AMERICAN JOURNAL OF PATHOLOGY

Lower mRNA and Protein Expression Levels of LC3 and Beclin1, Markers of Autophagy, were Correlated with Progression of Renal Clear Cell Carcinoma

(2013) Q. Deng et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

High expression of LC3B is associated with progression and poor outcome in triple-negative breast cancer

(2013) Hong Zhao et al.   MEDICAL ONCOLOGY

Therapeutic Silencing of Bcl-2 by Systemically Administered siRNA Nanotherapeutics Inhibits Tumor Growth by Autophagy and Apoptosis and Enhances the Efficacy of Chemotherapy in Orthotopic Xenograft Models of ER (−) and ER (+) Breast Cancer

(2013) Ibrahim Tekedereli et al.   Molecular Therapy-Nucleic Acids

Cancer genetics and genomics of human FOX family genes

(2012) Masuko Katoh et al.   CANCER LETTERS

Expression of autophagy-related markers beclin-1, light chain 3A, light chain 3B and p62 according to the molecular subtype of breast cancer

(2012) Junjeong Choi et al.   HISTOPATHOLOGY

Targeted Silencing of Elongation Factor 2 Kinase Suppresses Growth and Sensitizes Tumors to Doxorubicin in an Orthotopic Model of Breast Cancer

(2012) Ibrahim Tekedereli et al.   PLoS One

Pro-proliferative FoxM1 is a target of p53-mediated repression

(2009) A M Barsotti et al.   ONCOGENE